Initial trials of the spring-like postoperative sinus device known as the PROPEL stent were promising, which led many sinus surgeons such as myself to experience success with the device. But as with any technology, a much wider dataset becomes available once that device becomes available to the public.
Last week the manufacturers released the results of a large study to determine the efficacy of the Propel stent. Their conclusions were emphatic:
The study met its primary efficacy endpoint, demonstrating a statistically significant 38% relative reduction in the need for post-operative interventions, such as the need for additional surgical procedures or need for oral steroid prescription, compared to surgery alone. The device placement success rate was 100% and there were no device-related adverse events.
The Propel stent uses mechanical action (the shape) and medical action (the release of steroids) to aid the body’s sinuses as they heal. If you’d like to speak with an expert sinus surgeon who can help you decide whether to use the Propel stent in your own recovery, please contact us today.